Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer. [electronic resource]
Producer: 20111206Description: 1131-3 p. digitalISSN:- 1744-7682
No physical items for this record
Publication Type: Editorial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.